Nykode Therapeutics

Biotech —

Contact person

Michael Engsig

Nykode Therapeutics is an Oslo-based clinical-stage biopharmaceutical platform company founded in 2007. Our bold aim is to generate game-changing therapeutics to treat cancers and infectious diseases with a high unmet medical need.

With our unique and innovative modular vaccine technology, we’re specifically targeting antigens to Antigen Presenting Cells, which are essential for inducing rapid, strong and long-lasting immune responses.